Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to navigate catheters, guidewires, and other delivery devices through the blood vessels and heart chambers to treatment sites; and Vdrive Robotic Navigation System, which provides navigation and stability for the diagnostic and ablation devices that assist in the delivery of ablations. The company also offers Odyssey solution, which provides integrated and real-time information solution to manage, control, record, and share procedures across networks; acquires a real-time and remote view of the lab capturing synchronized procedure data for the review of events during cases; enable physicians to access recorded cases and create snapshots following procedures for clinical reporting, auditing, and presenting; and enables physicians to establish a master archive of procedures performed in the lab. In addition, it provides disposables and other accessories, such as Cardiodrive or QuikCAS automated catheter advancement disposables for the advancement of electrophysiology catheters; CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters; and a suite of Cronus, Assert, Titan, and Pegasus coronary guide wires used in the interventional cardiology procedures. Further, the company offers V-CAS catheter and V-CAS Deflect integrated catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. It has strategic alliances with Siemens AG Medical Solutions, Philips Medical Systems, and Biosense Webster, Inc. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Key Statistics